Daniel Spratt, MD
Dr. Spratt discusses the validation of an MMAI prognostic biomarker and how the model further stratifies risk in men with hig [...]
Ashley Evan Ross, MD, PHD
Dr. Ross discusses external validation of an MMAI prognostic model in patients with high- and very high-risk disease. Additio [...]
Felix Feng, MD
Dr. Feng discusses the development and validation of pathology-based deep learning predictive and prognostic tools to persona [...]
Jonathan D. Tward, MD, PHD, FASTRO
Dr. Tward discusses how an MMAI prognostic risk stratification model can further risk-stratify within a given NCCN risk group [...]
Osama Mohamad, MD
Dr. Mohamad discusses the development and validation of multimodal AI-based predictive and prognostic biomarkers for localize [...]
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase 3 clinical trials.
Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal thera [...]